› Forums › General Melanoma Community › Survey
- This topic has 8 replies, 4 voices, and was last updated 3 years, 8 months ago by
ed williams.
- Post
-
- June 23, 2021 at 10:03 am
The MRF has a survey which is focused on the impact of diagnostics testing on the patient experience. This survey is in no way promoting a diagnostic tool- it is simply wanting to know if there is an impact of diagnostic testing in regards to choosing treatments and also on the patient’s social emotional well-being.To participate please click the link
https://www.surveymonkey.com/r/6S8VBFW
- Replies
-
-
- June 23, 2021 at 3:41 pm
For a survey that is not to promote a specific diagnostic test, it sure uses the words ” Decision DX” in a lot of the question!!! Asking for a friend, do you find it hard to stretch the truth when you talk about having no $$$ interest in the Decision DX product promotion. This was not a survey about diagnostic testing, it was a Decision DX data collection request. The last time you used the forum to promote this company I asked you a question about when did the FDA approved this test for melanoma, the answer then as it is today is that it is not approved as a standard of care in melanoma for staging early stage patients. -
- June 23, 2021 at 4:00 pm
To advance the development of new diagnostic tools the MRF collaborates with multiple partners who are committed to ensuring the patient perspective is included in their mission against melanoma. As an organization, we share this commitment to making sure the patient voice is elevated during the development of prevention, diagnostic and treatment resources.-
- June 23, 2021 at 8:30 pm
That was a great response, but I must ask you why did you write in your original post that ” this survey is in no way promoting a diagnostic tool” . I completed the survey and it was all about Decision DX and only about Decision DX which again is running a clinical trial (see following link) but is not approved by the FDA. Is this going to be the new standard, to promote non FDA approved treatments in melanoma? Here is most recent update of the trial of Decision DX GEP test, that I could find, if I am missing some information please feel free to correct me. https://clinicaltrials.gov/ct2/show/NCT02355574 -
- June 23, 2021 at 8:40 pm
You might also find this recent article of interest on the topic of GEP test, and you might recognize some of the co-authors names on the list, since they are melanoma experts and some of the top pathology experts in the world. https://pubmed.ncbi.nlm.nih.gov/32725204/ -
- June 23, 2021 at 8:58 pm
Also Dr. Michael A Marchetti of Memorial Sloan Kettering was led author on this recent paper about GEP test that didn’t shine a very positive light on them. https://pubmed.ncbi.nlm.nih.gov/32745161/
-
- June 23, 2021 at 10:05 pm
Great work, Ed. It is extremely important to clarify what has actually been determined by melanoma experts as to how any test or treatment will really impact clinical decisions and the lives of melanoma patients. I fear that MRF is failing to recognize their role in regard to this forum; failing to note the perception of patients who think that what MRF reps say and publish is tantamount to an endorsement of what the patient should do; and failing to draw a clear line between an option to participate and helping promote the goals of a company who will be making a great deal of money on the backs of melanoma patients using a test that has yet to be found valuable by melanoma experts. This survey is clearly a marketing technique to get out name recognition and sell this product. If MRF can’t recognize that, I don’t know how they can call themselves patient advocates. Finally, this forum has never been the place for ANYBODY – MRF representatives, company goons, or anyone else to butt in. This forum is for patients and caregivers. PERIOD.Given that we have all learned to negotiate this sadly “updated” site, we can surely manage to look at other pages of the MRF website for these grand offerings should we wish. We don’t need them SOLD to us here. Especially by those whose actual paying job it is to advocate for our lives and the existence of this space.
This is a place that has afforded comfort, accurate information, and comradery to many over a great number of years. It has been heartbreaking to see participation dwindle. I fear that continued efforts like the unabashed promotion of one company’s product will only fuel more decline.
Hang tough peeps. Search for complete, authentic, accurate answers. Read critically. Make the decisions that are best for you and yours based on what melanoma specialists recommend rather than the hot new thing one company wants you to purchase. Your lives depend on it.
Ever yours, celeste
-
- June 24, 2021 at 9:29 am
Thank you, Ed and Celeste, for clearing this up for those of us who weren’t familiar with “Decision DX” testing. I received an email from MRF about the survey but had no idea what this was until I read this thread. Appreciate your dedication to keeping us all informed!Jenn
-
- June 24, 2021 at 2:49 pm
Hi Jenn, so if I understand what you wrote correctly, the MRF sent you an email, asking you to fill in this survey about the Decision DX GEP test. I guess I must have been put in the do not contact category by MRF since I didn’t get an email. Crazy times at the MRF for sure!!!
-
- You must be logged in to reply to this topic.